Testing effectiveness (Phase 2)Study completedNCT01233232
What this trial is testing
A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Who this might be right for
Scientific Terminology Chronic Obstructive Pulmonary Disease (COPD)Laymen Terminology Chronic Bronchitis and Emphysema
AstraZeneca 109